Cases 61 - 70 of 542
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00092
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Inc. et al v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01782
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Cause Of Action: 35 U.S.C. § 271
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
as 22-1258
Plaintiff / Appellee:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant / Appellant:
TEVA PHARMACEUTICALS USA, INC., MYLAN LABORATORIES LIMITED and MYLAN LABORATORIES LTD.
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc.
as 1:2021cv01619
Plaintiff:
Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH and Cephalon, Inc.
Defendant:
Hospira, Inc.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals Development, Inc. et al
as 1:2021cv01353
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, LLC, et al., v. Dr. Reddys Laboratories, Ltd., et al.,
as 1:2021cv01348
Plaintiff:
Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. and Anacor Pharmaceuticals, LLC
Defendant:
Alkem Laboratories Ltd., Dr. Reddys Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BIOMARIN PHARMACEUTICAL INC. et al v. TEVA PHARMACEUTICALS, INC. f/k/a TEVA PHARMACEUTICALS DEVELOPMENT, INC.
as 2:2021cv15392
Plaintiff:
BIOMARIN PHARMACEUTICAL INC. and MERCK & CIE
Defendant:
TEVA PHARMACEUTICALS, INC. f/k/a TEVA PHARMACEUTICALS DEVELOPMENT, INC.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01148
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Lotus Pharmaceutical Co., Ltd. et al
as 1:2021cv01107
Plaintiff:
Novartis Pharmaceuticals Corporation and Dana-Farber Cancer Institute, Inc.
Defendant:
Lotus Pharmaceutical Co., Ltd. and Teva Pharmaceuticals Development, Inc.
Cause Of Action: 35 U.S.C. § 1
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
